The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of being considered in shortage by the Food and Drug Administration (FDA).

Ozempic and Wegovy may not have been developed if not for the insistence of Novo Nordisk's head of research, Mads Krogsgaard. Leadership at the Danish company in the early 1990s were skeptical ...

After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as "available" on the U.S. Food and Drug Administration's drug shortage list.

Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared. But the Danish pharmaceutical company's origins were motivated by ...

Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential adverse health affects of Ozempic and Wegovy. However, a more recent study indicates ...

All doses of Novo Nordisk's Wegovy and Ozempic are now available in the U.S following a two-year shortage, according to the FDA drug shortage list, which was updated Oct. 30. Previously ...

After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as "available" on the U.S. Food and Drug Administration's drug shortage list. The ...

Novo Nordisk’s popular weight-loss injection Wegovy and diabetes drug Ozempic, both known chemically as semaglutide, were until recently in shortage in the United States. Given all the ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% decrease in their body weight after ...

Wegovy sales reached 17.30 billion Danish kroner, up 81% and Ozempic sales increased 26% at constant currency to 29.80 billion Danish kroner. Lars Fruergaard Jørgensen, president and CEO ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current medications in alleviating symptoms. By Gina Kolata The blockbuster drug ...